Revenue,
USD US$ 17.24 Bn
Forecast Year,
USD US$ 37.4 Bn
CAGR, 2025 -
8.05
Report Coverage
Worldwide
Plasma Derived Medicine Market Size Analysis
Plasma Derived Medicine Market Size By Product 2024 to 2034 (USD )
| Product | 2024 | 2025 | 2026 | 2027 | 2028 | 2029 | 2030 | 2031 | 2032 | 2033 | 2034 |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Immunoglobin | 0.77 | 1.13 | 0.76 | 0.93 | 1.06 | 1.26 | 1.58 | 1.54 | 1.73 | 1.84 | 2.06 |
| Coagulation Factors | 6.04 | 6.14 | 6.78 | 7.48 | 7.91 | 8.29 | 9.26 | 9.95 | 10.70 | 11.40 | 12.46 |
| Albumin | 1.79 | 2.07 | 2.56 | 2.68 | 2.68 | 3.26 | 2.59 | 3.17 | 3.60 | 4.10 | 4.14 |
| Others | 8.64 | 9.29 | 10.03 | 10.67 | 11.84 | 12.58 | 14.01 | 14.99 | 16.00 | 17.26 | 18.72 |
Plasma Derived Medicine Market Size By Application 2024 to 2034 (USD )
| Application | 2024 | 2025 | 2026 | 2027 | 2028 | 2029 | 2030 | 2031 | 2032 | 2033 | 2034 |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Bleeding Disorders | 1.20 | 1.44 | 1.75 | 1.82 | 1.63 | 2.14 | 2.00 | 2.50 | 2.66 | 2.71 | 3.39 |
| Alpha-1 Antitrypsin Deficiency (AATD) | 0.52 | 0.37 | 0.58 | 0.27 | 0.23 | 0.36 | 0.69 | 0.65 | 0.64 | 0.34 | 0.80 |
| Pelvic Inflammatory Disease (PID) | 0.37 | 0.51 | 0.59 | 0.74 | 0.91 | 1.04 | 1.12 | 0.86 | 0.74 | 1.15 | 1.00 |
| Hereditary Angioedema (HAE) | 3.44 | 3.68 | 3.60 | 4.32 | 5.14 | 5.04 | 5.23 | 5.53 | 5.97 | 6.93 | 7.57 |
| Chronic Inflammatory Demyelinating Polyneuropathy | 2.26 | 2.67 | 2.87 | 2.99 | 3.64 | 3.78 | 4.20 | 3.84 | 5.18 | 5.03 | 6.01 |
| Guillian-Barre Syndrome | 2.49 | 2.78 | 3.05 | 3.06 | 3.22 | 3.82 | 3.78 | 3.91 | 4.42 | 5.43 | 4.83 |
| Multifocal Motor Neuropathy | 0.94 | 1.06 | 0.72 | 0.95 | 0.66 | 0.70 | 0.96 | 1.78 | 1.20 | 1.90 | 1.26 |
| Liver Disease | 0.65 | 0.30 | 0.82 | 0.56 | 0.67 | 0.51 | 0.97 | 1.32 | 1.27 | 0.78 | 0.70 |
| Primary Immune Thrombocytopenia | 1.06 | 1.02 | 1.33 | 1.26 | 2.07 | 1.60 | 1.19 | 1.76 | 1.92 | 1.71 | 2.08 |
| Infections | 1.47 | 1.74 | 1.47 | 1.83 | 1.38 | 2.06 | 2.41 | 2.49 | 2.87 | 3.04 | 3.45 |
| Other Orphan Diseases | 2.84 | 3.06 | 3.35 | 3.96 | 3.93 | 4.33 | 4.89 | 5.01 | 5.17 | 5.58 | 6.30 |
Plasma Derived Medicine Market Size By Distribution Channel 2024 to 2034 (USD )
| Distribution Channel | 2024 | 2025 | 2026 | 2027 | 2028 | 2029 | 2030 | 2031 | 2032 | 2033 | 2034 |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Hospital Pharmacies | 6.70 | 6.96 | 7.88 | 8.25 | 9.07 | 9.77 | 10.45 | 11.91 | 12.85 | 13.75 | 14.70 |
| Online Pharmacies | 3.78 | 3.89 | 4.21 | 4.41 | 4.72 | 5.51 | 5.56 | 5.75 | 6.19 | 6.59 | 7.67 |
| Retail Pharmacies | 6.76 | 7.78 | 8.04 | 9.08 | 9.71 | 10.11 | 11.42 | 11.98 | 13.00 | 14.27 | 15.02 |
Plasma Derived Medicine Market Size By Geography 2024 to 2034 (USD )
| Geography | 2024 | 2025 | 2026 | 2027 | 2028 | 2029 | 2030 | 2031 | 2032 | 2033 | 2034 |
|---|---|---|---|---|---|---|---|---|---|---|---|
| North America | 2.29 | 2.83 | 3.07 | 2.76 | 3.37 | 3.62 | 3.70 | 3.86 | 4.51 | 4.05 | 5.42 |
| Europe | 8.00 | 8.28 | 9.14 | 10.25 | 11.03 | 11.99 | 12.86 | 13.96 | 15.23 | 16.18 | 17.03 |
| Asia-pacific | 0.36 | 0.25 | 0.33 | 0.21 | 0.24 | 0.25 | 0.78 | 0.35 | 0.32 | 0.39 | 0.69 |
| Latin America | 1.93 | 2.04 | 2.09 | 2.62 | 2.38 | 2.59 | 2.68 | 3.37 | 3.32 | 3.88 | 3.91 |
| Middle East and Africa | 4.66 | 5.24 | 5.49 | 5.91 | 6.47 | 6.94 | 7.42 | 8.11 | 8.65 | 10.11 | 10.34 |
Proceed To Buy
Proceed To CheckoutMake Every Move Strategic. Get Insights, Fully Customized
- On-Demand Metrics & KPIs
- Industry-Specific Dashboards
- Quick Turnaround, No Compromises
Quick Contact
- NA : +1 804 441 9344
- APAC : +91 9356 9282 04
- EU : +44 7782 560 738
- sales@precedenceresearch.com